Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (81-90 of 455) with videos related to

Pageof 46
Sort By:
International Journal of Molecular Sciences|July 8, 2020
MSX1-A Potential Marker for Uterus-Preserving Therapy of Endometrial CarcinomasSimon Eppich, Christina Kuhn, Elisa Schmoeckel, et al.
Breast Care (Basel, Switzerland)|November 23, 2020
Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?Thomas Kolben, Maximilian Bardenhewer, Theresa M Kolben, et al.
MMW Fortschritte Der Medizin|December 13, 2017
[Breast cancer in male]Rachel Würstlein, Andreas Hesse, Alexander König, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapyAnca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
International Journal of Molecular Sciences|February 10, 2024
Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical CancerTilman L R Vogelsang, Elisa Schmoeckel, Nicole Elisabeth Topalov, et al.
Methods and Protocols|December 27, 2024
Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer OrganoidsSophia Hierlmayer, Liliia Hladchenko, Juliane Reichenbach, et al.
Therapeutic Advances in Drug Safety|August 28, 2023
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customersFlorian Schindler, Timo Schinkoethe, Sven Mahner, et al.
International Journal of Molecular Sciences|August 27, 2021
Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl OffspringHuixia Yang, Zhi Ma, Lin Peng, et al.
Gynecologic Oncology|January 7, 2010
Serum carbonic anhydrase IX during first-line therapy of ovarian cancerLinn Woelber, Volkmar Mueller, Christine Eulenburg, et al.
Journal of Medical Case Reports|March 22, 2022
Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case reportAlexandra Stefan, Marija Petkovic, Alexander König, et al.
Pageof 46

Showing results (81-90 of 455) with videos related to

Sort By:
Pageof 46
International Journal of Molecular Sciences|July 8, 2020
MSX1-A Potential Marker for Uterus-Preserving Therapy of Endometrial CarcinomasSimon Eppich, Christina Kuhn, Elisa Schmoeckel, et al.
Breast Care (Basel, Switzerland)|November 23, 2020
Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?Thomas Kolben, Maximilian Bardenhewer, Theresa M Kolben, et al.
MMW Fortschritte Der Medizin|December 13, 2017
[Breast cancer in male]Rachel Würstlein, Andreas Hesse, Alexander König, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapyAnca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
International Journal of Molecular Sciences|February 10, 2024
Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical CancerTilman L R Vogelsang, Elisa Schmoeckel, Nicole Elisabeth Topalov, et al.
Methods and Protocols|December 27, 2024
Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer OrganoidsSophia Hierlmayer, Liliia Hladchenko, Juliane Reichenbach, et al.
Therapeutic Advances in Drug Safety|August 28, 2023
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customersFlorian Schindler, Timo Schinkoethe, Sven Mahner, et al.
International Journal of Molecular Sciences|August 27, 2021
Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl OffspringHuixia Yang, Zhi Ma, Lin Peng, et al.
Gynecologic Oncology|January 7, 2010
Serum carbonic anhydrase IX during first-line therapy of ovarian cancerLinn Woelber, Volkmar Mueller, Christine Eulenburg, et al.
Journal of Medical Case Reports|March 22, 2022
Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case reportAlexandra Stefan, Marija Petkovic, Alexander König, et al.
Pageof 46